Medical bottles and syringe are seen with Eli Lilly and Company logo displayed on a screen in ... lowest doses of its popular weight loss drug Zepbound at approximately half the original price.

Diabetes drug Mountjaro has been on the list since 2022 and weight-loss drug Zepbound was added in April. The shortage has forced consumers to turn to drug compounders, who make equivalent ...

Eli Lilly's tirzepatide, sold as Zepbound for weight loss and Mounjaro to treat diabetes, has been in short supply since 2022 amid skyrocketing demand. The medication is part of the blockbuster ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

By Dani Blum The Food and Drug Administration on Wednesday declared an end to the two-year shortage of tirzepatide, the substance in the popular weight-loss medication Zepbound and the diabetes ...

The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 ...

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been resolved. Tirzepatide, the active ingredient in the diabetes and ...

The mayor of Rio de Janeiro is promising to make a generic version of Ozempic available through the city’s public health ...

U.S. drugmaker Eli Lilly said on Wednesday it will invest $4.5 billion to create a new center for advanced manufacturing and ...

The center, Lilly Medicine Foundry, will focus on researching new ways of producing medicines and scaling up the production ...